Pulmonx Corp (LUNG)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$114.7M
Stockholders' Equity
$39.2M
Cash & Equivalents
$55.8M
Long-Term Debt
$37.5M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Pulmonx Corp reported revenue of $22.8M, net income of -$10.1M, and total assets of $114.7M. Every figure below is taken directly from Pulmonx Corp's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2018–FY2025 · as reported

$90.5M$14.8M-$60.8M
FY2018FY2020FY2022FY2024FY2025
Revenue$90.5MNet income-$54.0M
FY2018 revenue
$20.0M
FY2025 revenue
$90.5M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$90.5M-$54.0M
FY2024$83.8M-$56.4M
FY2023$68.7M-$60.8M
FY2022$53.7M-$58.9M
FY2021$48.4M-$48.7M
FY2020$32.7M-$32.2M
FY2019$32.6M-$20.7M
FY2018$20.0M-$18.5M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 27, 2026on EDGAR ↗
10-QAug 4, 2026on EDGAR ↗
8-KJul 29, 2026on EDGAR ↗
8-KJun 4, 2026on EDGAR ↗
10-QMay 4, 2026on EDGAR ↗
8-KApr 29, 2026on EDGAR ↗
DEF 14AApr 22, 2026on EDGAR ↗
10-KMar 10, 2026on EDGAR ↗
8-KMar 5, 2026on EDGAR ↗
8-KMar 4, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$114.7Msource ↗
Stockholders’ Equity$39.2Msource ↗
Cash & Equivalents$55.8Msource ↗
Long-Term Debt$37.5Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$22.8Msource ↗
Net Income-$10.1Msource ↗
Operating Income-$9.1Msource ↗
Gross Profit$17.7Msource ↗
Cost of Revenue$5.0Msource ↗
R&D Expense$5.0Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.24source ↗
EPS (basic)$-0.24source ↗
Shares Outstanding42.9Msource ↗
Cash from Operations-$5.2Msource ↗
Cash from Financing-$513,000source ↗
Cash from Investing-$1,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
29
Net shares
-171.6K

Restatement history

Point-in-time

No material restatements detected across 240 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches LUNG’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LUNG

MCP tool: get_sec_fundamentals ticker=LUNG

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LUNG/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=LUNG as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LUNG/history

MCP tool: get_fundamentals_history ticker=LUNG

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/LUNG

MCP tool: get_financial_health ticker=LUNG

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.